You are here

Women's Imaging

 

Diffusion-weighted MRI (DWI) may soon command broader consideration than it’s been getting as a supplemental breast-screening tool. The modality not only finds many breast cancers that don’t show up on mammograms but also outperformed supplemental breast ultrasound in a study published online Oct. 28 in Clinical Imaging.

The U.S. Food and Drug Administration (FDA) issued an Oct. 27 reminder that thermography is not an acceptable substitute for mammography.

Screening mammography providers “on wheels” planning to serve medically underserved Latino communities would do well to first communicate with each community on perceptions of such services and, where needed, to offer education prior to rolling in.

Following screening mammography that turns up nothing, women with dense breast tissue are much more likely to pursue additional imaging with automated breast ultrasound (ABUS) when two things happen: their radiologists inform them of their tissue density and encourage them to consider the secondary exam because of it.

Image quality in mammography, thanks to concerns about radiation dose, faces a Goldilocks problem—where radiologists want to get the best image possible, while also minimizing risk to the patient. 

 

Recent Headlines

Breast lesions found incidentally on abdominal MRI shown cancerous at a considerable rate

Breast lesions seldom turn up incidentally in abdominal MRI scans. However, when they do, quite a few turn out to be malignant. Accordingly, radiologists interpreting women’s abdominal MRIs should be on the lookout for breast abnormalities.

Mammography info on hospital websites needs to be simplified

Few hospitals are providing information on mammography for patients at the recommended reading level or with references to professional guidelines, according to a study published in the journal AJR.

A game-changer is long overdue in breast-cancer research—and one may be just ahead

As far as we’ve come in the fight against breast cancer over the past 20 years, the state of actionable information is, circa 2016, fairly accurately encapsulated by an old bromide that’s often dispatched to denigrate perceptions of progress: The more things change, the more they stay the same.

Making 3D mammography a reality for all facilities

Countless studies have shown 3D mammography can reduce false positives and increases cancer detection in women with dense breasts, it creates a better overall patient experience, and insurance companies are finally beginning to cover costs associated with 3D mammograms.

Two studies validate efficacy of bioabsorbable breast cancer marker

A new implant to treat women with breast cancer has been deemed effective by two independent studies, an encouraging development for the bioabsorbable marker branded as BioZorb.

4 uses for contrast-enhanced spectral mammography

Researchers and clinicians from Cooper University Hospital have been using spectral mammography on a daily basis since November 2012. A group of residents, fellows and faculty from Cooper published a review of techniques and practical applications of contrast-enhanced spectral mammography (CESM) in Academic Radiology.

Breast imaging: Leading by example

The radiology subspecialty of breast imaging has its problems, not least the discord it deals with every day over screening scheduling. 

Ultrasound safely omitted in imaging workups of women with breast pain and normal density tissue

Clinicians evaluating women with nondense breasts who are experiencing focal breast pain will find little to no value adding directed ultrasound to digital mammography when the latter is indicated due to screening scheduling. 

Hard numbers put to screening mammography overdiagnosis

Over the years since the advent of widespread screening mammography, overdiagnosis and overtreatment have become accepted as unfortunate but tolerable collateral troubles. There’s no shortage of literature using mathematical modeling to suggest as much. Now comes a new analysis of hard data, published Oct. 13 in the New England Journal of Medicine, to quantify the problem. 

New method of gauging metastatic risk may help ovarian-cancer patients avoid unnecessary chest CTs

Researchers in the U.S. and South Korea have collaborated to create and validate an evidence-based rule that can accurately predict which women with ovarian cancer are not at significant risk for metastases in the chest and abdomen—and thus not really in need of some guideline-recommended CT scans.

Pages